Legal Representation
Attorney
Brian O'Donnell
USPTO Deadlines
Application History
8 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 5, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Jun 5, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Feb 20, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Feb 20, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Feb 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Feb 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 23, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 20, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of ophthalmic diseases; medicated and non-medicated eye drops; pharmaceutical preparations, serums and injectables for the treatment of retinal or choroidal disease
First Use Anywhere:
Dec 21, 2022
First Use in Commerce:
Dec 21, 2022
Classification
International Classes
005